12566596Blesa R, Davidson M, Kurz A, Reichman W, van Baelen B, Schwalen SDementia and geriatric cognitive disordersAlzheimer Disease; Cholinesterase Inhibitors; GalantamineAged; Double-Blind Method; Humans; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment OutcomeGalantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months. Dement Geriatr Cogn Disord. 2003; 15(2):79-87.Dement Geriatr Cogn Disord2003-01-01T00:00:002003Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.294764AgedD005702Chemicals & Drugs110.999713GalantamineD004311Procedures33818220.708936Double-Blind MethodAuthorship 219792D006801Living Beings2262862810.130052HumansD013997Concepts & Ideas118351980.519628Time Factors0.05736240.05736241authors10.2510has subject areaD016896Concepts & Ideas101179490.402389Treatment OutcomeD011569Concepts & IdeasProcedures954860.849443Psychiatric Status Rating ScalesD012720Concepts & Ideas54117960.64922Severity of Illness IndexD000544Disorders974700.73465Alzheimer DiseaseD002800Chemicals & Drugs27450.978783Cholinesterase InhibitorsUniversity of ChicagoMichael H.DavidsonMichael H. Davidson41.78927490000000-87.60125000000000611Davidson, Michael H.Clinical Professortrue1Clinical ProfessorClinical ProfessorMedicine-Cardiology